MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm11164786

Медицинская библиотека · Journal of clinical medicine · 2022

Immune Checkpoint Inhibitors' Associated Renal Toxicity: A Series of 12 Cases.

Palamaris Kostas, Alexandris Dimitrios, Stylianou Kostas, Giatras Ioannis, Stofas Anastasios, Kaitatzoglou Christina, Migkou Magda, Goutas Dimitrios, Psimenou Erasmia, Theodoropoulou Eleni, Theocharis Stamatios, Alevizopoulos Nektarios, Kastritis Efstathios, Gerakis Alexandros, Gakiopoulou Harikleia

СтатьяПеревод в очереди

Аннотация

We present a series of twelve patients, bearing a wide range of solid malignancies, who received either PD-L1 or a combination of PD-L1 and CTLA-4 inhibitors. Following immunotherapy administration, they exhibited the clinical signs indicative of renal toxicity, including increased serum creatinine levels, proteinuria, nephrotic syndrome and/or hematuria. All patients underwent renal biopsy.

Results

All cases demonstrated some degree of interstitial inflammation and tubular injury, while in five patients, glomerular alterations consistent with a specific glomerulopathy were also observed: secondary "lupus-like" membranous glomerulopathy in two cases and membranoproliferative glomerulonephritis, IgA glomerulonephritis and secondary AA amyloidosis in each of the remaining three patients. The two patients with "lupus-like" nephritis and the one with amyloidosis experienced nephrotic syndrome, while their creatinine was within normal range. In the remaining nine cases, deterioration of renal function was the main manifestation.

Conclusion

Our findings harmonize with bibliographical data that identify tubulointerstitial nephritis as the most frequent histological lesion related to ICIs administration. The preferential involvement of tubulointerstitial tissue could be associated with the reported higher expression levels of PD-L1 on tubular epithelial cells, compared to glomeruli. On the other hand, glomerular involvement is probably a consequence of a systemic immune system reconstruction, induced by immune-checkpoints inhibition.

Для цитирования: Palamaris Kostas, Alexandris Dimitrios, Stylianou Kostas, Giatras Ioannis, Stofas Anastasios, Kaitatzoglou Christina, Migkou Magda, Goutas Dimitrios, Psimenou Erasmia, Theodoropoulou Eleni, Theocharis Stamatios, Alevizopoulos Nektarios, Kastritis Efstathios, Gerakis Alexandros, Gakiopoulou Harikleia. Immune Checkpoint Inhibitors' Associated Renal Toxicity: A Series of 12 Cases.. Journal of clinical medicine. 2022. DOI: 10.3390/jcm11164786.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.